These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 3293764)

  • 1. Complete pathologic maturation and regression of stage IVS neuroblastoma without treatment.
    Haas D; Ablin AR; Miller C; Zoger S; Matthay KK
    Cancer; 1988 Aug; 62(4):818-25. PubMed ID: 3293764
    [TBL] [Abstract][Full Text] [Related]  

  • 2. N-myc oncogene and urinary catecholamines in children with neuroblastoma.
    Barontini M; Gutiérrez MI; Levin G; Mur N; Diez B
    Med Pediatr Oncol; 1993; 21(7):499-504. PubMed ID: 8341218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The neuroblastoma.
    Koop CE
    Prog Pediatr Surg; 1972; 4():1-28. PubMed ID: 4570199
    [No Abstract]   [Full Text] [Related]  

  • 4. Neuroblastoma detected by mass screening: the Tumor Board's role in its treatment.
    Okazaki T; Kohno S; Mimaya J; Hasegawa S; Urushihara N; Yoshida A; Kawano S; Kusafuka J; Horikoshi Y; Takashima Y; Aoki K; Hamazaki M
    Pediatr Surg Int; 2004 Jan; 20(1):27-32. PubMed ID: 14689211
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum vanillylmandelic acid/homovanillic acid contributes to prognosis estimation in patients with localised but not with metastatic neuroblastoma.
    Berthold F; Hunneman DH; Harms D; Käser H; Zieschang J
    Eur J Cancer; 1992; 28A(12):1950-4. PubMed ID: 1419287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Different genomic and metabolic patterns between mass screening-positive and mass screening-negative later-presenting neuroblastomas.
    Nakagawara A; Zaizen Y; Ikeda K; Suita S; Ohgami H; Nagahara N; Sera Y; Akiyama H; Kawakami K; Uchino J
    Cancer; 1991 Nov; 68(9):2037-44. PubMed ID: 1913552
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spontaneous Maturation of Neuroblastoma to Ganglioneuroma: Two Case Studies.
    Yao ZG; Liu XM; Qin YJ
    Fetal Pediatr Pathol; 2016; 35(6):410-415. PubMed ID: 27362946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N-Myc gene amplification is a major prognostic factor in localized neuroblastoma: results of the French NBL 90 study. Neuroblastoma Study Group of the Société Francaise d'Oncologie Pédiatrique.
    Rubie H; Hartmann O; Michon J; Frappaz D; Coze C; Chastagner P; Baranzelli MC; Plantaz D; Avet-Loiseau H; Bénard J; Delattre O; Favrot M; Peyroulet MC; Thyss A; Perel Y; Bergeron C; Courbon-Collet B; Vannier JP; Lemerle J; Sommelet D
    J Clin Oncol; 1997 Mar; 15(3):1171-82. PubMed ID: 9060561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spontaneous regression of neuroblastoma.
    Evans AE; Gerson J; Schnaufer L
    Natl Cancer Inst Monogr; 1976 Nov; 44():49-54. PubMed ID: 1030781
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N-myc oncogene and stage IV-S neuroblastoma. Preliminary observations on ten cases.
    Nakagawara A; Sasazuki T; Akiyama H; Kawakami K; Kuwano A; Yokoyama T; Kume K
    Cancer; 1990 May; 65(9):1960-7. PubMed ID: 2196987
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Survival from locally invasive or widespread neuroblastoma without cytotoxic therapy.
    Kushner BH; Cheung NK; LaQuaglia MP; Ambros PF; Ambros IM; Bonilla MA; Gerald WL; Ladanyi M; Gilbert F; Rosenfield NS; Yeh SD
    J Clin Oncol; 1996 Feb; 14(2):373-81. PubMed ID: 8636746
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroblastoma stage IV-S.
    Miale TD; Kirpekar K
    Med Oncol; 1994; 11(3-4):89-100. PubMed ID: 7633837
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Flow cytometric DNA analysis of neuroblastoma and ganglioneuroma. A 10-year retrospective study.
    Taylor SR; Blatt J; Costantino JP; Roederer M; Murphy RF
    Cancer; 1988 Aug; 62(4):749-54. PubMed ID: 3395958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ganglioneuroma : primary tumor or maturation of a suspected neuroblastoma?
    Przkora R; Perez-Canto A; Ertel W; Heyde CE
    Eur Spine J; 2006 Mar; 15(3):363-5. PubMed ID: 16047206
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stage and urinary catecholamine metabolite excretion in neuroblastoma. European Neuroblastoma Study Group.
    Pritchard J; Barnes J; Germond S; Hartman O; de Kraker J; Lewis I; Lockwood L; Wallendszus K
    Lancet; 1989 Aug; 2(8661):514-5. PubMed ID: 2570230
    [No Abstract]   [Full Text] [Related]  

  • 16. Diagnostic and prognostic markers in infants with disseminated neuroblastoma: a retrospective analysis from the Italian Cooperative Group for Neuroblastoma.
    Di Cataldo A; Dau D; Conte M; Parodi S; De Bernardi B; Giuliano M; Pession A; Viscardi E; Luksch R; Castellano A; Bertuna G; Haupt R;
    Med Sci Monit; 2009 Jan; 15(1):MT11-8. PubMed ID: 19114976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between high levels of expression of the TRK gene and favorable outcome in human neuroblastoma.
    Nakagawara A; Arima-Nakagawara M; Scavarda NJ; Azar CG; Cantor AB; Brodeur GM
    N Engl J Med; 1993 Mar; 328(12):847-54. PubMed ID: 8441429
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Telomerase activity distinguishes between neuroblastomas with good and poor prognosis.
    Poremba C; Willenbring H; Hero B; Christiansen H; Schäfer KL; Brinkschmidt C; Jürgens H; Böcker W; Dockhorn-Dworniczak B
    Ann Oncol; 1999 Jun; 10(6):715-21. PubMed ID: 10442195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deletion of chromosome 1p loci and microsatellite instability in neuroblastomas analyzed with short-tandem repeat polymorphisms.
    Martinsson T; Sjöberg RM; Hedborg F; Kogner P
    Cancer Res; 1995 Dec; 55(23):5681-6. PubMed ID: 7585654
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bilateral adrenal neuroblastoma.
    Ishiguro Y; Iio K; Seo T; Nagaya M; Ito T
    Eur J Pediatr Surg; 1994 Feb; 4(1):37-9. PubMed ID: 8199131
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.